Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (1949)
All Articles published online
|
Jan 28, 2007 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Sebastiani G, Vario A, Guido M, Alberti A. Sequential algorithms combining non-invasive markers and biopsy for the assessment of liver fibrosis in chronic hepatitis B. World J Gastroenterol 2007; 13(4): 525-531 [PMID: 17278217 DOI: 10.3748/wjg.v13.i4.525] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v13/i4/525.htm |
| Number | Citing Articles |
| 1 |
Naglaa A.A. Allam, Maha M. El Sabawy, Eman Abdelsamea, Wesam S. Morad, Nermine A. Ehsan. Noninvasive markers of liver disease in patients with HBeAg negative chronic hepatitis B and normal enzymes. Egyptian Liver Journal 2015; 5(4): 68 doi: 10.1097/01.ELX.0000475733.77229.b7
|
| 2 |
Stella M. Martínez, Gonzalo Crespo, Miquel Navasa, Xavier Forns. Noninvasive assessment of liver fibrosis. Hepatology 2011; 53(1): 325 doi: 10.1002/hep.24013
|
| 3 |
引 张. Research Progress of Serological Index in Diagnosis of Liver Fibrosis. Medical Diagnosis 2022; 12(02): 89 doi: 10.12677/MD.2022.122014
|
| 4 |
Giada Sebastiani, Konstantinos Gkouvatsos, Mario Plebani. Non-invasive assessment of liver fibrosis: it is time for laboratory medicine. cclm 2011; 49(1): 13 doi: 10.1515/CCLM.2011.001
|
| 5 |
Vincent Leroy, Nathalie Sturm, Patrice Faure, Candice Trocme, Alice Marlu, Marie-Noëlle Hilleret, Françoise Morel, Jean-Pierre Zarski. Prospective evaluation of FibroTest®, FibroMeter®, and HepaScore® for staging liver fibrosis in chronic hepatitis B: Comparison with hepatitis C. Journal of Hepatology 2014; 61(1): 28 doi: 10.1016/j.jhep.2014.02.029
|
| 6 |
Sheng-di Wu, Yan-jun Ni, Li–li Liu, Hai Li, Lun-gen Lu, Ji-Yao Wang. Establishment and validation of a simple noninvasive model to predict significant liver fibrosis in patients with chronic hepatitis B. Hepatology International 2012; 6(1): 360 doi: 10.1007/s12072-011-9328-1
|
| 7 |
Manoj Kumar, Ashish Kumar, Syed Hissar, Pankaj Jain, Archana Rastogi, Deepak Kumar, Puja Sakhuja, Shiv K. Sarin. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus. Liver International 2008; 28(5): 690 doi: 10.1111/j.1478-3231.2008.01711.x
|
| 8 |
Mehmet Celikbilek, Serkan Dogan, Sebnem Gursoy, Gokmen Zararsız, Alper Yurci, Omer Ozbakır, Kadri Guven, Mehmet Yucesoy. Noninvasive assessment of liver damage in chronic hepatitis B. World Journal of Hepatology 2013; 5(8): 439-444 doi: 10.4254/wjh.v5.i8.439
|
| 9 |
Razika Bouzitoune, Mahmoud Meziri, Christiano Bittencourt Machado, Frédéric Padilla, Wagner Coelho de Albuquerque Pereira. Can early hepatic fibrosis stages be discriminated by combining ultrasonic parameters?. Ultrasonics 2016; 68: 120 doi: 10.1016/j.ultras.2016.02.014
|
| 10 |
Sehhoon Park, Hwi Young Kim, Haeryoung Kim, Jin Hyun Park, Jung Ho Kim, Ki Hwan Kim, Won Kim, In Sil Choi, Yong Jin Jung, Jin-Soo Kim. Changes in Noninvasive Liver Fibrosis Indices and Spleen Size During Chemotherapy. Medicine 2016; 95(2): e2454 doi: 10.1097/MD.0000000000002454
|
| 11 |
Federica Branchi, Clara Benedetta Conti, Alessandra Baccarin, Pietro Lampertico, Dario Conte, Mirella Fraquelli. Non-invasive assessment of liver fibrosis in chronic hepatitis B. World Journal of Gastroenterology 2014; 20(40): 14568-14580 doi: 10.3748/wjg.v20.i40.14568
|
| 12 |
Bogdan A. Stana, Evelina Moraru, Alice Azoicăi, Valentin Munteanu, Doina Mihăilă, Roxana Mihaela Barbu. Updates regarding the pathophysiology of liver cirrhosis in children. Pediatru.ro 2020; 4(60): 21 doi: 10.26416/Pedi.60.4.2020.4073
|
| 13 |
Hanyu Jiang, Tianying Zheng, Ting Duan, Jie Chen, Bin Song. Non-invasive in vivo Imaging Grading of Liver Fibrosis. Journal of Clinical and Translational Hepatology 2018; 6(2): 1 doi: 10.14218/JCTH.2017.00038
|
| 14 |
Manuel Rodríguez, María Luisa González-Diéguez. Tratamiento del paciente con hepatitis crónica por el virus de la hepatitis B. Enfermedades Infecciosas y Microbiología Clínica 2008; 26: 56 doi: 10.1016/S0213-005X(08)76520-0
|
| 15 |
Giada Sebastiani. Non-invasive assessment of liver fibrosis in chronic liver diseases: Implementation in clinical practice and decisional algorithms. World Journal of Gastroenterology 2009; 15(18): 2190-2203 doi: 10.3748/wjg.15.2190
|
| 16 |
Hesham M. Abu Gabal, Helmy M. Elshazly, Nabil A. Omar, Hossam A. Taha. Noninvasive predictors for the presence of gastroesophageal varices in patients with liver cirrhosis. Egyptian Liver Journal 2011; 1(2): 51 doi: 10.1097/01.ELX.0000397032.63789.56
|
| 17 |
Julie Bottero, Karine Lacombe, Jérôme Guéchot, Lawrence Serfaty, Patrick Miailhes, Philippe Bonnard, Dominique Wendum, Jean-Michel Molina, Caroline Lascoux-Combe, Pierre-Marie Girard. Performance of 11 biomarkers for liver fibrosis assessment in HIV/HBV co-infected patients. Journal of Hepatology 2009; 50(6): 1074 doi: 10.1016/j.jhep.2009.01.022
|
| 18 |
H. L.‐Y. Chan, G. L.‐H. Wong, P. C.‐L. Choi, A. W.‐H. Chan, A. M.‐L. Chim, K. K.‐L. Yiu, F. K.‐L. Chan, J. J.‐Y. Sung, V. W.‐S. Wong. Alanine aminotransferase‐based algorithms of liver stiffness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. Journal of Viral Hepatitis 2009; 16(1): 36 doi: 10.1111/j.1365-2893.2008.01037.x
|
| 19 |
Leon A Adams. Biomarkers of liver fibrosis. Journal of Gastroenterology and Hepatology 2011; 26(5): 802 doi: 10.1111/j.1440-1746.2010.06612.x
|
| 20 |
M. Pinzani, F. Vizzutti. Liver Cirrhosis: From Pathophysiology to Disease Management. 2008; 162: 163 doi: 10.1007/978-1-4020-8656-4_15
|
| 21 |
A.S.F. Lok. Hepatitis B: Liver fibrosis and hepatocellular carcinoma. Gastroentérologie Clinique et Biologique 2009; 33(10-11): 911 doi: 10.1016/j.gcb.2009.06.001
|
| 22 |
Won‐Mook Choi, Jeong‐Hoon Lee, Hongkeun Ahn, Hyeki Cho, Young Youn Cho, Minjong Lee, Jeong‐ju Yoo, Yuri Cho, Dong Hyeon Lee, Yun Bin Lee, Eun Ju Cho, Su Jong Yu, Nam‐Joon Yi, Kwang‐Woong Lee, Yoon Jun Kim, Jung‐Hwan Yoon, Kyung‐Suk Suh, Chung Yong Kim, Hyo‐Suk Lee. Forns index predicts recurrence and death in patients with hepatitis B‐related hepatocellular carcinoma after curative resection. Liver International 2015; 35(8): 1992 doi: 10.1111/liv.12776
|
| 23 |
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2015; : 1 doi: 10.1007/978-94-007-7742-2_2-1
|
| 24 |
Navneet Kaur, Gitanjali Goyal, Ravinder Garg, Chaitanya Tapasvi, Sonia Chawla, Rajneet Kaur. Potential role of noninvasive biomarkers during liver fibrosis. World Journal of Hepatology 2021; 13(12): 1919-1935 doi: 10.4254/wjh.v13.i12.1919
|
| 25 |
Yuan Cao, Kun He, Ming Cheng, Hai-Yan Si, He-Lin Zhang, Wei Song, Ai-Ling Li, Cheng-Jin Hu, Na Wang. Two Classifiers Based on Serum Peptide Pattern for Prediction of HBV-Induced Liver Cirrhosis Using MALDI-TOF MS. BioMed Research International 2013; 2013: 1 doi: 10.1155/2013/814876
|
| 26 |
H. Ben Ayed, M. Koubaa, S. Yaich, K. Rekik, T. Ben Jemaa, I. Maaloul, C. Marrekchi, J. Damak, M. Ben Jemaa. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Médecine et Maladies Infectieuses 2019; 49(8): 607 doi: 10.1016/j.medmal.2019.02.004
|
| 27 |
G. Sebastiani, L. Castera, P. Halfon, S. Pol, A. Mangia, V. Di Marco, M. Pirisi, M. Voiculescu, M. Bourliere, A. Alberti. The impact of liver disease aetiology and the stages of hepatic fibrosis on the performance of non-invasive fibrosis biomarkers: an international study of 2411 cases. Alimentary Pharmacology & Therapeutics 2011; 34(10): 1202 doi: 10.1111/j.1365-2036.2011.04861.x
|
| 28 |
Salvatore Petta, Calogero Cammà, Vito Di Marco, Nicola Alessi, Daniela Cabibi, Rosalia Caldarella, Anna Licata, Fatima Massenti, Giuseppe Tarantino, Giulio Marchesini, Antonio Craxì. Insulin Resistance and Diabetes Increase Fibrosis in the Liver of Patients With Genotype 1 HCV Infection. The American Journal of Gastroenterology 2008; 103(5): 1136 doi: 10.1111/j.1572-0241.2008.01813.x
|
| 29 |
R. MORRA, M. MUNTEANU, P. BEDOSSA, D. DARGERE, J.‐L. JANNEAU, V. PARADIS, V. RATZIU, F. CHARLOTTE, V. THIBAULT, F. IMBERT‐BISMUT, T. POYNARD. Diagnostic value of serum protein profiling by SELDI‐TOF ProteinChip compared with a biochemical marker, FibroTest, for the diagnosis of advanced fibrosis in patients with chronic hepatitis C. Alimentary Pharmacology & Therapeutics 2007; 26(6): 847 doi: 10.1111/j.1365-2036.2007.03427.x
|
| 30 |
Tarek A Besheer, Mahmoud M El-Bendary, Khaled R Zalata, Hossam E Zaghalol. Evaluation of Fibrosis Progression by
Noninvasive Biochemical Markers in
Egyptian Patients with Chronic Hepatitis B. Euroasian Journal of Hepato-Gastroenterology 2011; 1(2): 71 doi: 10.5005/jp-journals-10018-1016
|
| 31 |
Huanming Xiao, Meijie Shi, Yubao Xie, Xiaoling Chi, Ferruccio Bonino. Comparison of diagnostic accuracy of magnetic resonance elastography and Fibroscan for detecting liver fibrosis in chronic hepatitis B patients: A systematic review and meta-analysis. PLOS ONE 2017; 12(11): e0186660 doi: 10.1371/journal.pone.0186660
|
| 32 |
Giada Sebastiani, Kostas Pantopoulos. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice. Metallomics 2011; 3(10): 971 doi: 10.1039/c1mt00082a
|
| 33 |
Dominique Thabut, Marika Simon‐Rudler. Evidence‐Based Gastroenterology and Hepatology. 2010; : 554 doi: 10.1002/9781444314403.ch35
|
| 34 |
Jérôme Boursier, Nina Dib, Frédéric Oberti, Paul Calès. Caractéristiques et interprétation des tests sanguins de fibrose hépatique. Gastroentérologie Clinique et Biologique 2007; 31(5): 511 doi: 10.1016/S0399-8320(07)89421-8
|
| 35 |
Ali Riza Koksal, Huseyin Alkim, Salih Boga, Meltem Ergun, Mehmet Bayram, Banu Yilmaz Ozguven, Canan Alkim. Effect of Entecavir and Tenofovir Treatment on Noninvasive Fibrosis Scores. American Journal of Therapeutics 2016; 23(2): e429 doi: 10.1097/MJT.0000000000000203
|
| 36 |
Jung Won Yun, Yong Kyun Cho, Jung Ho Park, Hong Joo Kim, Dong Il Park, Chong Il Sohn, Woo Kyu Jeon, Byung Ik Kim, Byung Ho Son, Jun Ho Shin. Hepatic steatosis and fibrosis in young men with treatment‐naïve chronic hepatitis B. Liver International 2009; 29(6): 878 doi: 10.1111/j.1478-3231.2009.01976.x
|
| 37 |
Catriona Crossan, Emmanuel A Tsochatzis, Louise Longworth, Kurinchi Gurusamy, Brian Davidson, Manuel Rodríguez-Perálvarez, Konstantinos Mantzoukis, Julia O’Brien, Evangelos Thalassinos, Vassilios Papastergiou, Andrew Burroughs. Cost-effectiveness of non-invasive methods for assessment and monitoring of liver fibrosis and cirrhosis in patients with chronic liver disease: systematic review and economic evaluation. Health Technology Assessment 2015; 19(9): 1 doi: 10.3310/hta19090
|
| 38 |
Sujata Lall, Pragya Agarwala, Guresh Kumar, Manoj Kumar Sharma, Ekta Gupta. The dilemma of differentiating between acute hepatitis B and chronic hepatitis B with acute exacerbation: Is quantitative serology the answer?. Clinical and Molecular Hepatology 2020; 26(2): 187 doi: 10.3350/cmh.2019.0060
|
| 39 |
Hong-Bo Liu, Jian-Ping Zhou, Yong Zhang, Xiao-Hui Lv, Wei Wang. Prediction on liver fibrosis using different APRI thresholds when patient age is a categorical marker in patients with chronic hepatitis B. Clinica Chimica Acta 2011; 412(1-2): 33 doi: 10.1016/j.cca.2010.08.032
|
| 40 |
G. Sebastiani, D. Tempesta, A. Alberti. Hepatic iron overload is common in chronic hepatitis B and is more severe in patients coinfected with hepatitis D virus. Journal of Viral Hepatitis 2012; 19(2) doi: 10.1111/j.1365-2893.2011.01508.x
|
| 41 |
Karin L. Andersson, Raymond T. Chung. Monitoring during and after antiviral therapy for hepatitis B. Hepatology 2009; 49(S5): S166 doi: 10.1002/hep.22899
|
| 42 |
J. Á. Cuenca-Gómez, J. Salas-Coronas, A. B. Lozano-Serrano, J. Vázquez-Villegas, M. J. Soriano-Pérez, M. Estévez-Escobar, A. Villarejo-Ordóñez, M. T. Cabezas-Fernández. Hepatitis B and Schistosoma co-infection in a non-endemic area. European Journal of Clinical Microbiology & Infectious Diseases 2016; 35(9): 1487 doi: 10.1007/s10096-016-2689-6
|
| 43 |
Kyu Sik Jung, Seung Up Kim. Clinical applications of transient elastography. Clinical and Molecular Hepatology 2012; 18(2): 163 doi: 10.3350/cmh.2012.18.2.163
|
| 44 |
Nermin N Salkic, Predrag Jovanovic, Goran Hauser, Majda Brcic. FibroTest/Fibrosure for Significant Liver Fibrosis and Cirrhosis in Chronic Hepatitis B: A Meta-Analysis. American Journal of Gastroenterology 2014; 109(6): 796 doi: 10.1038/ajg.2014.21
|
| 45 |
Fatma Demet Arslan, Inanc Karakoyun, Bengu Tatar, Emel Ebru Pala, Mustafa Yıldırım, Celal Ulasoglu, Can Duman, Harun Akar, Sukran Kose, Banu Isbilen Basok. SHFI: A Novel Noninvasive Predictive Model for Significant Fibrosis in Patients With Chronic Hepatitis B. Hepatitis Monthly 2018; 18(2) doi: 10.5812/hepatmon.63310
|
| 46 |
Maria Guido. Practical Hepatic Pathology: a Diagnostic Approach. 2018; : 233 doi: 10.1016/B978-0-323-42873-6.00016-0
|
| 47 |
Prowpanga Udompap, Kamonthip Sukonrut, Voraparee Suvannarerg, Ananya Pongpaibul, Phunchai Charatcharoenwitthaya. Prospective comparison of transient elastography, point shear wave elastography, APRI and FIB‐4 for staging liver fibrosis in chronic viral hepatitis. Journal of Viral Hepatitis 2020; 27(4): 437 doi: 10.1111/jvh.13246
|
| 48 |
Thierry Poynard, Rachel Morra, Patrick Ingiliz, Françoise Imbert‐Bismut, Dominique Thabut, Djamila Messous, Mona Munteanu, Julien Massard, Yves Benhamou, Vlad Ratziu. . Advances in Clinical Chemistry 2008; 46: 131 doi: 10.1016/S0065-2423(08)00404-6
|
| 49 |
I.N. Guha, W.M. Rosenberg. Noninvasive Assessment of Liver Fibrosis: Serum Markers, Imaging, and Other Modalities. Clinics in Liver Disease 2008; 12(4): 883 doi: 10.1016/j.cld.2008.07.010
|
| 50 |
Beom Kyung Kim, Seung Up Kim, Hyon Suk Kim, Jun Yong Park, Sang Hoon Ahn, Chae Yoon Chon, In Rae Cho, Dong-Hoo Joh, Young Nyun Park, Kwang-Hyub Han, Do Young Kim, Man-Fung Yuen. Prospective Validation of FibroTest in Comparison with Liver Stiffness for Predicting Liver Fibrosis in Asian Subjects with Chronic Hepatitis B. PLoS ONE 2012; 7(4): e35825 doi: 10.1371/journal.pone.0035825
|
| 51 |
Kwang Gyun Lee, Yeon Seok Seo, Hyonggin An, Soon Ho Um, Eun Suk Jung, Bora Keum, Hyung Joon Yim, Yoon Tae Jeen, Hoon Jai Chun, Chang Duck Kim, Ho Sang Ryu. Usefulness of non‐invasive markers for predicting liver cirrhosis in patients with chronic hepatitis B. Journal of Gastroenterology and Hepatology 2010; 25(1): 94 doi: 10.1111/j.1440-1746.2009.05953.x
|
| 52 |
Agnieszka Bakula, Maciej Dadalski. Biomarkers in Liver Disease. Biomarkers in Disease: Methods, Discoveries and Applications 2017; : 305 doi: 10.1007/978-94-007-7675-3_2
|
| 53 |
Danan Wang, Qinghui Wang, Fengping Shan, Beixing Liu, Changlong Lu. Identification of the risk for liver fibrosis on CHB patients using an artificial neural network based on routine and serum markers. BMC Infectious Diseases 2010; 10(1) doi: 10.1186/1471-2334-10-251
|
| 54 |
Mitsuru Ishizuka, Keiichi Kubota, Junji Kita, Mitsugi Shimoda, Masato Kato, Shozo Mori, Yukihiro Iso, Hidetsugu Yamagishi, Masaru Kojima. Aspartate aminotransferase-to-platelet ratio index is associated with liver cirrhosis in patients undergoing surgery for hepatocellular carcinoma. Journal of Surgical Research 2015; 194(1): 63 doi: 10.1016/j.jss.2014.09.009
|
| 55 |
Steven C. Greenway, David S. Crossland, Mark Hudson, Steven R. Martin, Robert P. Myers, Tim Prieur, Asif Hasan, Richard Kirk. Fontan-associated liver disease: Implications for heart transplantation. The Journal of Heart and Lung Transplantation 2016; 35(1): 26 doi: 10.1016/j.healun.2015.10.015
|
| 56 |
Philippe Halfon, Mona Munteanu, Thierry Poynard. FibroTest-ActiTest as a non-invasive marker of liver fibrosis. Gastroentérologie Clinique et Biologique 2008; 32(6): 22 doi: 10.1016/S0399-8320(08)73991-5
|
| 57 |
Xin Chen, Huiying Wen, Xinyu Zhang, Changfeng Dong, Haoming Lin, Yanrong Guo, Lingbo Shan, Simin Yao, Min Yang, Xiaohua Le, Yingxia Liu. Development of a Simple Noninvasive Model to Predict Significant Fibrosis in Patients with Chronic Hepatitis B: Combination of Ultrasound Elastography, Serum Biomarkers, and Individual Characteristics. Clinical and Translational Gastroenterology 2017; 8(4): e84 doi: 10.1038/ctg.2017.11
|
| 58 |
Ambresh Ayyali, Shilpa A. Assesmentof Fibro Q test, AAR & APRI indices as markers of fibrosis in chronic liver disease. IP Indian Journal of Neurosciences 2021; 7(1): 39 doi: 10.18231/j.ijn.2021.007
|
| 59 |
Vincenza Calvaruso, Antonio Craxì. Implication of normal liver enzymes in liver disease. Journal of Viral Hepatitis 2009; 16(8): 529 doi: 10.1111/j.1365-2893.2009.01150.x
|
| 60 |
Paul A. Schmeltzer, Jayant A. Talwalkar. Noninvasive Tools to Assess Hepatic Fibrosis: Ready for Prime Time?. Gastroenterology Clinics of North America 2011; 40(3): 507 doi: 10.1016/j.gtc.2011.06.010
|
| 61 |
Amine Benmassaoud, Giada Sebastiani. Liver Elastography. 2020; : 563 doi: 10.1007/978-3-030-40542-7_49
|
| 62 |
Valentina Marchese, Anna Beltrame, Andrea Angheben, Stefania Marocco, Giovanni Battista Gaeta, Zeno Bisoffi. The impact of schistosomiasis co-infection in the presentation of viral hepatitis B in migrants: An observational study in non-endemic area. Travel Medicine and Infectious Disease 2020; 35: 101467 doi: 10.1016/j.tmaid.2019.101467
|
| 63 |
Thierry Poynard, Rachel Morra, Philippe Halfon, Laurent Castera, Vlad Ratziu, Françoise Imbert-Bismut, Sylvie Naveau, Dominique Thabut, Didier Lebrec, Fabien Zoulim, Marc Bourliere, Patrice Cacoub, Djamila Messous, Mona Munteanu, Victor de Ledinghen. Meta-analyses of FibroTest diagnostic value in chronic liver disease. BMC Gastroenterology 2007; 7(1) doi: 10.1186/1471-230X-7-40
|
| 64 |
Semra Sökücü, Selim Gökçe, Mine Güllüoğlu, Ayşen Aydoğan, Coşkun Çeltik, Özlem Durmaz. The role of the non-invasive serum marker FibroTest–ActiTest in the prediction of histological stage of fibrosis and activity in children with naïve chronic hepatitis B infection. Scandinavian Journal of Infectious Diseases 2010; 42(9): 699 doi: 10.3109/00365541003774616
|
| 65 |
Brenda Nherera, Kudakwashe Mhandire, Tinashe K. Nyazika, Alfred Makura, Cuthbert Musarurwa, Prichard T. Mapondera, Babill Stray-Pedersen, Hilda T. Matarira. Comparison of non-invasive methods of assessing liver fibrosis in combination ART-experienced Zimbabweans. Southern African Journal of HIV Medicine 2019; 20(1) doi: 10.4102/sajhivmed.v20i1.844
|
| 66 |
Da-Wu Zeng, Jing Dong, Yu-Rui Liu, Jia-Ji Jiang, Yue-Yong Zhu. Noninvasive models for assessment of liver fibrosis in patients with chronic hepatitis B virus infection. World Journal of Gastroenterology 2016; 22(29): 6663-6672 doi: 10.3748/wjg.v22.i29.6663
|
| 67 |
Ju‐Seop Kang, Min‐Ho Lee. Liver Cirrhosis - Update and Current Challenges. 2017; doi: 10.5772/intechopen.68317
|
| 68 |
Yong-Peng Chen, Jie Peng, Jin-Lin Hou. Non-invasive assessment of liver fibrosis in patients with chronic hepatitis B. Hepatology International 2013; 7(2): 356 doi: 10.1007/s12072-013-9439-y
|
| 69 |
Wenwen Jin, Zhonghua Lin, Yongning Xin, Xiangjun Jiang, Quanjiang Dong, Shiying Xuan. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis B-related fibrosis: a leading meta-analysis. BMC Gastroenterology 2012; 12(1) doi: 10.1186/1471-230X-12-14
|
| 70 |
Fasiha Kanwal, Jennifer R. Kramer, Steven M. Asch, Yumei Cao, Liang Li, Hashem B. El‐Serag. Long‐Term Risk of Hepatocellular Carcinoma in HCV Patients Treated With Direct Acting Antiviral Agents. Hepatology 2020; 71(1): 44 doi: 10.1002/hep.30823
|
| 71 |
Jérôme Boursier, Julien Vergniol, Apollinaire Sawadogo, Taoufiq Dakka, Sophie Michalak, Yves Gallois, Véronique Le Tallec, Frédéric Oberti, Isabelle Fouchard‐Hubert, Nina Dib, Marie Christine Rousselet, Anselme Konaté, Naïma Amrani, Victor De Ledinghen, Paul Calès. The combination of a blood test and Fibroscan improves the non‐invasive diagnosis of liver fibrosis. Liver International 2009; 29(10): 1507 doi: 10.1111/j.1478-3231.2009.02101.x
|
| 72 |
Laurent Castera. Assessing liver fibrosis. Expert Review of Gastroenterology & Hepatology 2008; 2(4): 541 doi: 10.1586/17474124.2.4.541
|
| 73 |
|
| 74 |
Massimo Pinzani, Francesco Vizzutti, Umberto Arena, Fabio Marra. Technology Insight: noninvasive assessment of liver fibrosis by biochemical scores and elastography. Nature Clinical Practice Gastroenterology & Hepatology 2008; 5(2): 95 doi: 10.1038/ncpgasthep1025
|
| 75 |
EASL-ALEH Clinical Practice Guidelines: Non-invasive tests for evaluation of liver disease severity and prognosis. Journal of Hepatology 2015; 63(1): 237 doi: 10.1016/j.jhep.2015.04.006
|
| 76 |
Maria Guido. Practical Hepatic Pathology: A Diagnostic Approach. 2011; : 201 doi: 10.1016/B978-0-443-06803-4.00016-2
|
| 77 |
Marija Zeremski, Rositsa B Dimova, Samantha Benjamin, Jessy Makeyeva, Rhonda K Yantiss, Maya Gambarin-Gelwan, Andrew H Talal. FibroSURE as a noninvasive marker of liver fibrosis and inflammation in chronic hepatitis B. BMC Gastroenterology 2014; 14(1) doi: 10.1186/1471-230X-14-118
|
| 78 |
Iraj Shahramian, Manijeh Khalili, Alireza Sargazi, Alireza Dechal, Mostafa Bazi, Masoud Jahantigh, Mojtaba Delaramnasab, Ali Bazi. Non-Invasive Markers of Liver Fibrosis in Children with Chronic Hepatic Disorders. Gene, Cell and Tissue 2020; 7(3) doi: 10.5812/gct.101443
|
| 79 |
Thierry Poynard, Yen Ngo, Mona Munteanu, Dominique Thabut, Vlad Ratziu. Noninvasive Markers of Hepatic Fibrosis in Chronic Hepatitis B. Current Hepatitis Reports 2011; 10(2): 87 doi: 10.1007/s11901-011-0096-0
|
| 80 |
Baiying Lei, Yingxia Liu, Changfeng Dong, Xin Chen, Xinyu Zhang, Xianfen Diao, Guilin Yang, Jing Liu, Simin Yao, Hanying Li, Jing Yuan, Shaxi Li, Xiaohua Le, Yimin Lin, Wen Zeng. Assessment of liver fibrosis in chronic hepatitis B via multimodal data. Neurocomputing 2017; 253: 169 doi: 10.1016/j.neucom.2016.09.128
|
| 81 |
Abdel Aziz M. Shaheen, Robert P. Myers. Diagnostic accuracy of the aspartate aminotransferase-to-platelet ratio index for the prediction of hepatitis C–related fibrosis: A systematic review. Hepatology 2007; 46(3): 912 doi: 10.1002/hep.21835
|
| 82 |
C Rinaldi A Lesmana, Simon Salim, Irsan Hasan, Andri S Sulaiman, Rino A Gani, Levina S Pakasi, Laurentius A Lesmana, Ening Krisnuhoni, Unggul Budihusodo. Diagnostic accuracy of transient elastography (FibroScan) versus the aspartate transaminase to platelet ratio index in assessing liver fibrosis in chronic hepatitis B: The role in primary care setting. Journal of Clinical Pathology 2011; 64(10): 916 doi: 10.1136/jclinpath-2011-200044
|
| 83 |
Laurent Castera. Hepatitis B: are non‐invasive markers of liver fibrosis reliable?. Liver International 2014; 34(s1): 91 doi: 10.1111/liv.12393
|
| 84 |
Gonzalo Crespo, Guillermo Fernández-Varo, Zoe Mariño, Gregori Casals, Rosa Miquel, Stella M. Martínez, Rosa Gilabert, Xavier Forns, Wladimiro Jiménez, Miquel Navasa. ARFI, FibroScan®, ELF, and their combinations in the assessment of liver fibrosis: A prospective study. Journal of Hepatology 2012; 57(2): 281 doi: 10.1016/j.jhep.2012.03.016
|
| 85 |
T. Poynard, Y. Ngo, P. Marcellin, S. Hadziyannis, V. Ratziu, Y. Benhamou. Impact of adefovir dipivoxil on liver fibrosis and activity assessed with biochemical markers (FibroTest–ActiTest) in patients infected by hepatitis B virus. Journal of Viral Hepatitis 2009; 16(3): 203 doi: 10.1111/j.1365-2893.2008.01065.x
|
| 86 |
Ki Tae Suk, Dae Yong Kim, Kyoung Min Sohn, Dong Joon Kim. . Advances in Clinical Chemistry 2013; 62: 33 doi: 10.1016/B978-0-12-800096-0.00002-0
|
| 87 |
Masaru Enomoto, Hiroyasu Morikawa, Akihiro Tamori, Norifumi Kawada. Noninvasive assessment of liver fibrosis in patients with chronic hepatitis B. World Journal of Gastroenterology 2014; 20(34): 12031-12038 doi: 10.3748/wjg.v20.i34.12031
|
| 88 |
Hind I. Fallatah. Noninvasive Biomarkers of Liver Fibrosis: An Overview. Advances in Hepatology 2014; 2014: 1 doi: 10.1155/2014/357287
|
| 89 |
Laurent Castera. Transient elastography and other noninvasive tests to assess hepatic fibrosis in patients with viral hepatitis. Journal of Viral Hepatitis 2009; 16(5): 300 doi: 10.1111/j.1365-2893.2009.01087.x
|
| 90 |
Thomas Pembroke, Giada Sebastiani. Diagnostic Methods for Cirrhosis and Portal Hypertension. 2018; : 63 doi: 10.1007/978-3-319-72628-1_5
|
| 91 |
Giada Sebastiani, Konstantinos Gkouvatsos, Kostas Pantopoulos. Chronic hepatitis C and liver fibrosis. World Journal of Gastroenterology 2014; 20(32): 11033-11053 doi: 10.3748/wjg.v20.i32.11033
|
| 92 |
Papa Saliou Mbaye, Anna Sarr, Jean-Marie Sire, Marie-Louise Evra, Adama Ba, Jean Daveiga, Aboubakry Diallo, Fatou Fall, Loic Chartier, François Simon, Muriel Vray, Young Nyun Park. Liver Stiffness Measurement and Biochemical Markers in Senegalese Chronic Hepatitis B Patients with Normal ALT and High Viral Load. PLoS ONE 2011; 6(7): e22291 doi: 10.1371/journal.pone.0022291
|
| 93 |
Yen Ngo, Yves Benhamou, Vincent Thibault, Patrick Ingiliz, Mona Munteanu, Pascal Lebray, Dominique Thabut, Rachel Morra, Djamila Messous, Frederic Charlotte, Françoise Imbert-Bismut, Dominique Rousselot-Bonnefont, Joseph Moussalli, Vlad Ratziu, Thierry Poynard, Niyaz Ahmed. An Accurate Definition of the Status of Inactive Hepatitis B Virus Carrier by a Combination of Biomarkers (FibroTest-ActiTest) and Viral Load. PLoS ONE 2008; 3(7): e2573 doi: 10.1371/journal.pone.0002573
|
| 94 |
You-Xiang Zhang, Wen-Juan Wu, Yun-Zhi Zhang, Yan-Ling Feng, Xin-Xi Zhou, Qi Pan. Noninvasive assessment of liver fibrosis with combined serum aminotransferase/platelet ratio index and hyaluronic acid in patients with chronic hepatitis B. World Journal of Gastroenterology 2008; 14(46): 7117-7121 doi: 10.3748/wjg.14.7117
|
| 95 |
Massimo Pinzani. Non-invasive systems for staging compensated cirrhosis. Arab Journal of Gastroenterology 2010; 10(4): S32 doi: 10.1016/j.ajg.2009.12.002
|
| 96 |
Dirk J. Van Leeuwen, Charles Balabaud, James M. Crawford, Paulette Bioulac–Sage, Amar P. Dhillon. A Clinical and Histopathologic Perspective on Evolving Noninvasive and Invasive Alternatives for Liver Biopsy. Clinical Gastroenterology and Hepatology 2008; 6(5): 491 doi: 10.1016/j.cgh.2008.02.023
|
| 97 |
Ömer Başar, Barış Yımaz, Fuat Ekiz, Zeynep Giniş, Akif Altınbaş, Bora Aktaş, Yaşar Tuna, Şahin Çoban, Namık Delibaş, Osman Yüksel. Non-invasive tests in prediction of liver fibrosis in chronic hepatitis B and comparison with post-antiviral treatment results. Clinics and Research in Hepatology and Gastroenterology 2013; 37(2): 152 doi: 10.1016/j.clinre.2012.07.003
|
| 98 |
L. Castéra, P.-H. Bernard, B. Le Bail, J. Foucher, P. Trimoulet, W. Merrouche, P. Couzigou, V. de Lédinghen. Transient elastography and biomarkers for liver fibrosis assessment and follow-up of inactive hepatitis B carriers. Alimentary Pharmacology & Therapeutics 2011; 33(4): 455 doi: 10.1111/j.1365-2036.2010.04547.x
|
| 99 |
Rachel Morra, Mona Munteanu, Françoise Imbert-Bismut, Djamila Messous, Vlad Ratziu, Thierry Poynard. FibroMAX™: towards a new universal biomarker of liver disease?. Expert Review of Molecular Diagnostics 2007; 7(5): 481 doi: 10.1586/14737159.7.5.481
|
| 100 |
Laurent Castera. Noninvasive Methods to Assess Liver Disease in Patients With Hepatitis B or C. Gastroenterology 2012; 142(6): 1293 doi: 10.1053/j.gastro.2012.02.017
|
| 101 |
Salil Ginde, Mark D. Hohenwalter, W. Dennis Foley, Jane Sowinski, Peter J. Bartz, Suneetha Venkatapuram, Catherine Weinberg, James S. Tweddell, Michael G. Earing. Noninvasive Assessment of Liver Fibrosis in Adult Patients Following the Fontan Procedure. Congenital Heart Disease 2012; 7(3): 235 doi: 10.1111/j.1747-0803.2012.00632.x
|